White Sage › Blog › GLP-1 Therapy
GLP-1 THERAPY
Will You Gain the Weight Back After Stopping Ozempic or Wegovy?
Yes, most people regain a substantial portion of what they lost. But regain isn't automatic, it isn't total, and it isn't a willpower failure. Here's what the research actually found, why it happens, and what changes the outcome.
It is the question I get asked most often, usually near the end of a first appointment, and usually in a slightly lowered voice: "If I start this, am I on it forever?"
It is an important question, and we discuss it before starting treatment. Research shows that many people regain a substantial amount of weight after stopping these medications. That does not mean treatment failed or that you did something wrong. It means long-term maintenance deserves a plan of its own.
But that sentence is not the whole story, and the rest of it is genuinely more hopeful. Regain is not automatic, it is not total, and it is not a moral event. It has specific, identifiable causes, and most of them can be planned for.
What the research actually found
Two large trials followed people after the medication was withdrawn, and their findings line up closely.
In the STEP 1 trial extension, participants who had lost an average of 17.3% of their body weight on semaglutide were followed for a full year after stopping. They regained 11.6 percentage points of that (roughly two-thirds), leaving them about 5.6% below where they started.
SURMOUNT-4 tested the same question with tirzepatide, and did it more rigorously. Everyone lost weight for 36 weeks first, averaging 20.9%. Then half continued the medication and half switched to placebo, without knowing which. Over the next year the placebo group gained 14% of their body weight back. The group who continued lost another 5.5%.
What happened after treatment stopped
| WHAT HAPPENED | SEMAGLUTIDE (STEP 1 EXTENSION) | TIRZEPATIDE (SURMOUNT-4) |
|---|---|---|
| Weight lost on treatment | 17.3% over 68 weeks | 20.9% over 36 weeks |
| One year after stopping | Regained 11.6 percentage points | Regained 14% of body weight |
| Where they ended up | 5.6% below starting weight | 9.9% below starting weight |
| If they had continued | Not tested in this extension | 25.3% below starting weight |
A 2026 analysis pooled six of these trials together and found that regain follows a remarkably predictable curve. It is fastest in the first few months, then slows. At the one-year mark, about 40% of the original weight loss was still there. The model projects that regain would eventually level off at around three-quarters of what was lost, though that part is extrapolated beyond the twelve months actually observed.
That last number is worth sitting with, because it complicates the doom-and-gloom version of this story.
In the tirzepatide data the pattern was even clearer: the more weight someone regained, the further their waist circumference, blood pressure, cholesterol and insulin drifted back. Weight regain and loss of some health benefits can occur together, which is exactly why I treat maintenance as part of the treatment rather than as an afterthought.
Why it happens, and why it is not a willpower problem
This is the part I most want people to understand, because almost everyone who regains weight assumes it says something about their character. It does not. It says something about physiology, and the physiology is genuinely stacked against you.
Your appetite hormones do not reset. A landmark study followed people for a year after significant weight loss and measured the hormones that govern hunger and fullness. Ghrelin (the hormone that makes you hungry) was still elevated at twelve months. Leptin, which signals fullness, was still suppressed. So were several others. The authors' conclusion was blunt: a year after losing weight, these signals had not returned to where they started. Your body is still, hormonally, trying to get the weight back.
Your metabolism runs slower than your new size predicts. After weight loss, your body generally needs fewer calories. Some people also experience an additional reduction in energy expenditure, along with increased hunger. These adaptations can make maintaining weight loss more difficult.
The two combine into a gap you cannot feel. Researchers have put rough numbers on this. For every kilogram lost, appetite rises by roughly 100 calories a day, while energy expenditure falls by only about 20 to 30. Appetite is doing three to five times more of the work than the metabolic slowdown is. At a typical plateau, that adds up to an appetite pushing 400 to 600 calories a day harder than it did before, operating entirely below conscious awareness.
A GLP-1 medication works precisely on that gap. It quiets the hunger signal, slows stomach emptying and makes a smaller amount of food feel like enough. Remove it, and the gap is still there. Nothing has repaired it; the medication was holding it closed.
What we actually know about coming off
Here I want to be careful, because this is where a lot of confident marketing outruns the evidence.
The current standard of care, reflected in the American Diabetes Association's 2026 guidance, is to continue obesity medication after reaching your goal rather than stopping, specifically because discontinuation so often brings the weight and the cardiometabolic risk back with it. Obesity is treated as a chronic condition, in the same way high blood pressure is. Nobody expects a blood pressure medication to cure hypertension so it can be stopped.
You will also see clinics advertising taper protocols, microdosing, and off-ramping programs, often described as though they were established science. They are not. As of today there is no randomized controlled trial of dose reduction or extended dosing intervals for weight maintenance. The published data amounts to small retrospective case series and pharmacokinetic modelling. The largest is thirty patients with no control group, who moved from weekly injections to usually every other week and held their weight over about eight months. That is encouraging and it is worth knowing about. It is not proof, and the authors said so themselves.
So the honest position is this: continuing at an effective dose is what the evidence supports. Reducing frequency is something we can consider thoughtfully, with monitoring, in the right person, as a reasonable clinical decision, not a proven protocol. Anyone promising you a guaranteed exit strategy is telling you something the research does not yet support.
What actually protects you
Three things move the needle, and none of them are exotic.
Protein and strength training. An international expert consensus published in 2025 put numbers to this: roughly 1.2 to 1.5 grams of protein per kilogram of body weight per day during active weight loss, at least 0.8 grams per kilogram during maintenance, and two to three resistance training sessions a week alongside regular aerobic activity. This is not general wellness advice. These strategies support nutrition and muscle health while appetite and food intake change.
Medication plus structured exercise. In a year-long randomized trial, people who combined a GLP-1 with structured exercise did roughly twice as well on body fat as either approach alone, and the exercise groups were the ones who held onto lean mass. Roughly double, from adding one thing.
Ongoing clinical support. Clinical trials help us understand what can happen after treatment stops. In practice, the next step depends on why you are stopping, your health, medication access and your preferences. Continued follow-up allows us to reassess the plan if hunger, weight or health markers change.
How long, then?
The honest answer is that it depends on you, and I would be suspicious of anyone who says otherwise before knowing your labs.
One situation does have a clear answer: a planned pregnancy. Because semaglutide stays in the body a long time, the label directs stopping at least two months before trying to conceive, and stopping as soon as a pregnancy is recognized. If that is on your horizon at all, tell me early. It changes the timing of everything else.
Maintenance decisions are individualized. We review treatment benefits, side effects, nutrition, health conditions, cost and your preferences. Any change in dose or dosing schedule should be discussed with your prescriber, with follow-up to assess how you respond.
Whatever your starting goal, we build treatment around your long-term health. That includes nutrition, strength, sustainable habits and an ongoing conversation about medication. At White Sage Metabolic Studio, maintenance planning begins with your first appointment.
Frequently asked questions
Will I definitely gain the weight back if I stop?
Most people regain a substantial portion, but not all of it. In the semaglutide trial extension, participants regained about two-thirds of their loss within a year. In a 2026 pooled analysis of six trials, roughly 40% of the original weight loss was still present at one year. How much you regain depends heavily on how much muscle you protected on the way down and whether the nutrition and activity changes stayed in place.
How long do people usually stay on a GLP-1?
Current guidance treats obesity as a chronic condition and recommends continuing medication after reaching your goal, rather than stopping. In practice, length of treatment is an individual decision we revisit regularly based on your labs, your body composition and how you are doing, not a fixed course with an end date.
Can I lower my dose instead of stopping completely?
It is a reasonable thing to consider, and some people do well on a reduced dose or a longer interval between injections. I want to be straightforward that this is not yet backed by randomized evidence. The supporting data is a handful of small case series. We would approach it as a careful, monitored trial rather than a guaranteed protocol.
Why do the health markers go back too?
Because most of the improvement in blood pressure, blood sugar and triglycerides comes from the weight loss and the metabolic changes underneath it. When the weight returns, those drivers return with it. In the trial extension data, blood pressure and HbA1c were back near their original levels within a year of stopping.
Does this mean the medication did not work?
No. It means it works while it is working, which is true of most medications for chronic conditions. Blood pressure rises again when a blood pressure medication is stopped, and nobody concludes it failed. The useful question is not whether the medication is a cure, but whether the plan around it is built to last.References
The question isn't whether you'll stop. It's what happens if you do.
At White Sage Metabolic Studio, maintenance is part of the plan from the first appointment, not a conversation we have once the weight is off. If you'd like to talk through what a long-term approach would look like for you specifically, that's what a metabolic evaluation is for.
SCHEDULE A METABOLIC EVALUATIONPrefer to talk first? Call (801) 383-0105
